The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2019

Filed:

Oct. 02, 2009
Applicants:

Jørgen Schøller, Lyngby, DK;

Henrik Pedersen, Lynge, DK;

Liselotte Brix, Bagsværd, DK;

Inventors:

Jørgen Schøller, Lyngby, DK;

Henrik Pedersen, Lynge, DK;

Liselotte Brix, Bagsværd, DK;

Assignee:

Dako Denmark A/S, Glostrup, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/21 (2006.01); A61K 39/12 (2006.01); A61K 47/61 (2017.01); C07K 14/74 (2006.01); A61K 47/64 (2017.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); A61K 47/61 (2017.08); A61K 47/646 (2017.08); C07K 14/70539 (2013.01); A61K 38/00 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55583 (2013.01); A61K 2039/6087 (2013.01); A61K 2039/625 (2013.01); C12N 2740/16134 (2013.01); C12N 2740/16234 (2013.01); Y02A 50/464 (2018.01);
Abstract

The present invention relates to methods for construction of pharmamers i.e. vaccine components characterized by their multimerization domain and the attached biologically active molecules, and their use in preparation of vaccines that contains the pharmamers alone or in combination with other molecules. The individual molecules of the construct can be bound to each other or the multimerization domain(s) by covalent or non-covalent bonds, directly or via linkers. The invention further relates to the use of such preparations in vaccine settings aimed to function as preventive/prophylactic or therapeutic vaccines in humans and animals.


Find Patent Forward Citations

Loading…